Brief Summary
Currently there is a nationwide epidemic in opioid abuse and overdose deaths. While the opioid epidemic is multi-factorial one major source of excess opioids may be over-prescribing in the post-operative period. There is wide variation in the prescribing practices for post-operative pain control and there is no standard of care for pain control after minor laparoscopic surgery in general or after gynecologic laparoscopy. There is also evidence to show that on average half of the opioids prescribed are unused by the patient. The aim of the study is to evaluate two opioid prescription regimens.
Brief Title
Ambulatory Gynecologic Surgery: Finding the Optimal Opioid Prescription
Detailed Description
This will be a randomized controlled study enrolling participants scheduled for outpatient minor laparoscopic gynecologic surgery. This is a two arm study consisting of 60 subjects in each arm. The participants will be randomized at the time of enrollment. We will use computer generated blocks of four participants. Both arms of participants will receive the same non-narcotic pain medication prescriptions which will include fifty tablets of acetaminophen 500mg (1-2 tablets every 6 hours as needed) and twenty-five tablets ibuprofen 600mg (1 tablet every 6 hours as needed). The arms will only differ in the number of tablets of oxycodone prescribed. In one arm (experimental) subjects will receive five tablets of oxycodone 5mg (1 tablet every 6 hours as needed) and the other arm (comparator) ten tablets of oxycodone 5mg (1 tablet every 6 hours as needed). Both prescription regimens are within the range of normal clinical practice for post-operative pain control.
The participants will receive a telephone call by administrative staff, who is not directly involved in the participants care or data collection for the study subjects, on postoperative day 1 and 7. The participants will all be scheduled for a 2- week post-operative follow up with the surgeon in the office. The primary outcome to be assessed will be number of opioids used by the participants at 24 hours and 7 days post-operative. The primary hypothesis is that participants prescribed only 5 tabs of oxycodone will not require more medication. The secondary hypothesis is that the pain scores between the two groups will not be different. The other variables being studied include the following: having had a post-operative bowel movement, presence of nausea, number of ibuprofen, acetaminophen tablets remaining, calls to the office prior to the follow up visit for pain issues, and urgent or emergency department visits for pain issues. These assessments will be asked during the brief telephone calls and also at the postoperative visit.
All participants will be given the clinic phone number and advised to call with any questions or clinical concerns. The participants will be advised if possible to return to a Montefiore Emergency Department or gynecologic provider in case of an urgent issue prior to the 2 week postoperative visit, as opposed to an outside facility.
The participants will receive a telephone call by administrative staff, who is not directly involved in the participants care or data collection for the study subjects, on postoperative day 1 and 7. The participants will all be scheduled for a 2- week post-operative follow up with the surgeon in the office. The primary outcome to be assessed will be number of opioids used by the participants at 24 hours and 7 days post-operative. The primary hypothesis is that participants prescribed only 5 tabs of oxycodone will not require more medication. The secondary hypothesis is that the pain scores between the two groups will not be different. The other variables being studied include the following: having had a post-operative bowel movement, presence of nausea, number of ibuprofen, acetaminophen tablets remaining, calls to the office prior to the follow up visit for pain issues, and urgent or emergency department visits for pain issues. These assessments will be asked during the brief telephone calls and also at the postoperative visit.
All participants will be given the clinic phone number and advised to call with any questions or clinical concerns. The participants will be advised if possible to return to a Montefiore Emergency Department or gynecologic provider in case of an urgent issue prior to the 2 week postoperative visit, as opposed to an outside facility.
Categories
Completion Date
Completion Date Type
Actual
Conditions
Surgery
Eligibility Criteria
Inclusion Criteria:
* Must be over 18 years of age
* Scheduled for outpatient gynecologic laparoscopy
Exclusion Criteria:
* Significant renal or liver disease is present that would alter prescribing patterns
* Chronic opioid use or abuse
* Allergy to acetaminophen, ibuprofen, other nsaids or narcotic medications
* Conversion of surgery to exploratory laparotomy
* Must be over 18 years of age
* Scheduled for outpatient gynecologic laparoscopy
Exclusion Criteria:
* Significant renal or liver disease is present that would alter prescribing patterns
* Chronic opioid use or abuse
* Allergy to acetaminophen, ibuprofen, other nsaids or narcotic medications
* Conversion of surgery to exploratory laparotomy
Inclusion Criteria
Inclusion Criteria:
* Must be over 18 years of age
* Scheduled for outpatient gynecologic laparoscopy
* Must be over 18 years of age
* Scheduled for outpatient gynecologic laparoscopy
Gender
Female
Gender Based
false
Keywords
ambulatory
narcotics
opioids
postoperative
gynecology
laparoscopy
pain
surgery
Healthy Volunteers
No
Last Update Post Date
Last Update Post Date Type
Actual
Last Update Submit Date
Minimum Age
18 Years
NCT Id
NCT03588910
Org Class
Other
Org Full Name
Montefiore Medical Center
Org Study Id
2018-8755
Overall Status
Completed
Phases
Phase 2
Primary Completion Date
Primary Completion Date Type
Actual
Official Title
Ambulatory Gynecologic Surgery: Finding the Optimal Postoperative Opioid Prescription
Primary Outcomes
Outcome Description
During the survey phone call on day 1, participants will be asked to report the total number of oxycodone tablets use since the surgery.
Outcome Measure
Number of Oxycodone Tablets Used Day 1
Outcome Time Frame
24 hours post-operative
Outcome Description
During the survey phone call on day 7, participants will be asked to report the total number of oxycodone tablets used since the surgery.
Outcome Measure
Number of Oxycodone Tablets Used as Reported by Participants 1 Week After Surgery
Outcome Time Frame
7 days post-operative
Secondary Outcomes
Outcome Description
Participants will be surveyed during the phone call survey to rate pain score on a scale from 0 (no pain), to 10 (severe pain)
Outcome Time Frame
1 day post operative
Outcome Measure
Self Reported Pain Score on Post Operative Day 1 (Numeric Pain Reporting Score: NRS)
Outcome Description
Participants will be surveyed during the phone call survey to rate pain score on a scale from 0 (no pain), to 10 (severe pain)
Outcome Time Frame
7 days post operative
Outcome Measure
Self Reported Pain Score on Post Operative Day 7 (Numeric Pain Reporting Score: NRS)
Outcome Description
By chart review, unscheduled interactions with the healthcare system related to pain will be counted.These will include phone calls related to pain, unscheduled visits to the office or emergency department
Outcome Time Frame
1 week post operative
Outcome Measure
Additional Contacts With Provider
Start Date
Start Date Type
Actual
Status Verified Date
First Post Date
First Post Date Type
Actual
First Submit Date
First Submit QC Date
Std Ages
Adult
Older Adult
Maximum Age Number (converted to Years and rounded down)
999
Minimum Age Number (converted to Years and rounded down)
18
Investigators
Investigator Type
Principal Investigator
Investigator Name
Kari Plewniak
Investigator Email
kplewnia@montefiore.org
Investigator Phone